August 20, 2014
“Personalized therapies for lung cancer treatment: a paradigm shift in systematical cancer therapy”
5PM in Mainz, Germany
Lecture Hall, Building 708, at University Medical Center Mainz
Professor Wolf is an internist and hematologist-oncologist, who coordinated the foundation of the “Center for Integrated Oncology” (CIO) at the University Hospital Cologne where he serves as its medical director and CEO. Professor Wolf has initiated the CIO lung cancer program and the “Lung Cancer Group Cologne” (LCGC). Since 2012, he is Professor for Translational Oncology at the University of Cologne.
Professor Büttner is Professor and Chairman of Institute for Pathology at the University Hospital Cologne, and Co-founder/Chief Scientific Officer of Targos Germany, working on biomarker discovery and development of companion diagnostics.
In 2010, Wolf and Büttner joined forces to set up the “Network for Genomic Medicine” (NGM) for lung cancer, a molecular screening network operating out of the CIO for the implementation of personalized therapies for lung cancer. The aim of NGM is to establish centralized genotyping and personalized therapies in North Rhine-Westphalia. NGM is one of the biggest genotyping platforms worldwide. The Lung Cancer Group Cologne is closely linked with the Network for Genomic Medicine for lung cancer and has set up a translational platform for the integration of early clinical trials, genomic analysis and molecular imaging techniques.